Novel prognostic biomarker TBC1D1 is associated with immunotherapy resistance in gliomas
BackgroundGlioma, an aggressive brain tumor, poses a challenge in understanding the mechanisms of treatment resistance, despite promising results from immunotherapy.MethodsWe identified genes associated with immunotherapy resistance through an analysis…